Results 211 to 220 of about 117,695 (339)

Inactivation of glutathione <i>S</i>-transferase alpha 4 blocks <i>Enterococcus faecalis</i>-induced bystander effect by promoting macrophage ferroptosis. [PDF]

Gut Microbes
Ju Y, Ma C, Huang L, Tao Y, Li T, Li H, Huycke MM, Yang Y, Wang X.   +8 more
europepmc   +1 more source

Letter: COVID-19 Pandemic-The Bystander Effect on Stroke Care in Michigan. [PDF]

Neurosurgery, 2020
Pandey AS, Daou BJ, Tsai JP, Zaidi SF, Salahuddin H, Gemmete JJ, Oliver MJ, Singer J, Elder TA, Mbabuike N, Adel JG, Gujrati Y, Saleemi MA, Siddiqui FM, Elias AE, Rehman MF, Marin H, Chebl AB, Kole M, Wilseck JM, Kazmierczak CD, Mick JM, Majjhoo AQ, Naravetla BR, Rayes M, Luqman AW, Richards BF, Kelkar P, Burgess R, Thompson BG, Chaudhary N, Mazaris PA, Qahwash O, Razak MA, Jumaa MA, Michigan Stroke Treatment Improvement Collaborative (MISTIC).   +35 more
europepmc   +1 more source

"I Wish I Had Help Earlier. We Could Have Been Happier Sooner." Overcoming the Bystander Effect in the Care for Alcohol-Dependent Parents. [PDF]

Front Psychol, 2021
Snoek A, Dijkstra BAG, Markus W, Van der Meer M, De Wert G, Horstkötter D.   +5 more
europepmc   +1 more source

Bystander Effect Induced by UV Radiation; why should we be interested?

, 2012
Maria Wideł
openalex   +1 more source

The impact of Foxp3+ regulatory T‐cells on CD8+ T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley   +1 more source

Preclinical studies of BB-1701, a HER2-targeting eribulin-containing ADC with potent bystander effect and ICD activity. [PDF]

Antib Ther
Wang Y, Xia B, Cao L, Yang J, Feng C, Jiang F, Li C, Gu L, Yang Y, Tian J, Cheng X, Furuuchi K, Fulmer J, Verdi A, Rybinski K, Soto A, Albone E, Uenaka T, Gong L, Liu T, Qin Q, Wei Z, Zhou Y.   +22 more
europepmc   +1 more source

Synchrotron X-Ray Radiation-Induced Bystander Effect: An Impact of the Scattered Radiation, Distance From the Irradiated Site and p53 Cell Status. [PDF]

Front Oncol, 2021
Lobachevsky P, Forrester HB, Ivashkevich A, Mason J, Stevenson AW, Hall CJ, Sprung CN, Djonov VG, Martin OA.   +8 more
europepmc   +1 more source

CD30-targeting immunoconjugates and bystander effects [PDF]

Nature Reviews Clinical Oncology, 2015
Shigeo, Masuda, Shigeru, Miyagawa, Nagako, Sougawa, Yoshiki, Sawa   +3 more
openaire   +2 more sources

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Poly(beta-amino ester) nanoparticles enable tumor-specific TRAIL secretion and a bystander effect to treat liver cancer. [PDF]

Mol Ther Oncolytics, 2021
Vaughan HJ, Zamboni CG, Radant NP, Bhardwaj P, Revai Lechtich E, Hassan LF, Shah K, Green JJ.   +7 more
europepmc   +1 more source